☰

Jonathan Maher, Ph.D. - Publications

Affiliations: 
2005 University of Kansas, Lawrence, KS, United States 
Area:
Toxicology, Molecular Biology, Genetics
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Clarke JD, Sharapova T, Lake AD, Blomme E, Maher J, Cherrington NJ. Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis. Journal of Applied Toxicology : Jat. 34: 726-32. PMID 24217942 DOI: 10.1002/Jat.2960  0.363
2011 Suzuki T, Maher J, Yamamoto M. Select heterozygous Keap1 mutations have a dominant-negative effect on wild-type Keap1 in vivo. Cancer Research. 71: 1700-9. PMID 21177379 DOI: 10.1158/0008-5472.Can-10-2939  0.361
2010 Taguchi K, Maher JM, Suzuki T, Kawatani Y, Motohashi H, Yamamoto M. Genetic analysis of cytoprotective functions supported by graded expression of Keap1. Molecular and Cellular Biology. 30: 3016-26. PMID 20404090 DOI: 10.1128/Mcb.01591-09  0.338
2010 Maher J, Yamamoto M. The rise of antioxidant signaling--the evolution and hormetic actions of Nrf2. Toxicology and Applied Pharmacology. 244: 4-15. PMID 20122947 DOI: 10.1016/J.Taap.2010.01.011  0.344
2009 Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, Ohtsuki M, Goto N, Sugimoto H, Utsunomiya H, Oda K, Warabi E, Ishii T, Yamamoto M. Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. Biochemical and Biophysical Research Communications. 389: 431-6. PMID 19732748 DOI: 10.1016/J.Bbrc.2009.08.156  0.44
2008 Mamiya T, Katsuoka F, Hirayama A, Nakajima O, Kobayashi A, Maher JM, Matsui H, Hyodo I, Yamamoto M, Hosoya T. Hepatocyte-specific deletion of heme oxygenase-1 disrupts redox homeostasis in basal and oxidative environments. The Tohoku Journal of Experimental Medicine. 216: 331-9. PMID 19060448 DOI: 10.1620/Tjem.216.331  0.353
2008 Maher JM, Aleksunes LM, Dieter MZ, Tanaka Y, Peters JM, Manautou JE, Klaassen CD. Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicological Sciences : An Official Journal of the Society of Toxicology. 106: 319-28. PMID 18757529 DOI: 10.1093/Toxsci/Kfn177  0.583
2008 Okada K, Shoda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, Ohtsuki M, Goto N, Takeda K, Utsunomiya H, Oda K, Warabi E, Ishii T, Osaka K, Hyodo I, et al. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology. 295: G735-47. PMID 18687751 DOI: 10.1152/Ajpgi.90321.2008  0.504
2008 Merrell MD, Jackson JP, Augustine LM, Fisher CD, Slitt AL, Maher JM, Huang W, Moore DD, Zhang Y, Klaassen CD, Cherrington NJ. The Nrf2 activator oltipraz also activates the constitutive androstane receptor. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 1716-21. PMID 18474683 DOI: 10.1124/Dmd.108.020867  0.735
2008 Tanaka Y, Chen C, Maher JM, Klaassen CD. Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2). Toxicological Sciences : An Official Journal of the Society of Toxicology. 101: 171-8. PMID 17959626 DOI: 10.1093/Toxsci/Kfm261  0.624
2008 Aleksunes LM, Slitt AL, Maher JM, Augustine LM, Goedken MJ, Chan JY, Cherrington NJ, Klaassen CD, Manautou JE. Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicology and Applied Pharmacology. 226: 74-83. PMID 17935745 DOI: 10.1016/J.Taap.2007.08.022  0.649
2007 Maher JM, Dieter MZ, Aleksunes LM, Slitt AL, Guo G, Tanaka Y, Scheffer GL, Chan JY, Manautou JE, Chen Y, Dalton TP, Yamamoto M, Klaassen CD. Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology (Baltimore, Md.). 46: 1597-610. PMID 17668877 DOI: 10.1002/Hep.21831  0.598
2007 Fisher CD, Augustine LM, Maher JM, Nelson DM, Slitt AL, Klaassen CD, Lehman-McKeeman LD, Cherrington NJ. Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 35: 995-1000. PMID 17353348 DOI: 10.1124/Dmd.106.014340  0.549
2007 Tanaka Y, Maher JM, Chen C, Klaassen CD. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Molecular Pharmacology. 71: 817-25. PMID 17151289 DOI: 10.1124/Mol.106.029033  0.577
2007 Slitt AL, Allen K, Morrone J, Aleksunes LM, Chen C, Maher JM, Manautou JE, Cherrington NJ, Klaassen CD. Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. Biochimica Et Biophysica Acta. 1768: 637-47. PMID 17141734 DOI: 10.1016/J.Bbamem.2006.10.008  0.654
2006 Aleksunes LM, Slitt AL, Maher JM, Dieter MZ, Knight TR, Goedken M, Cherrington NJ, Chan JY, Klaassen CD, Manautou JE. Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis. Cell Stress & Chaperones. 11: 356-63. PMID 17278884 DOI: 10.1379/Csc-217.1  0.653
2006 Tanaka Y, Chen C, Maher JM, Klaassen CD. Kupffer cell-mediated downregulation of hepatic transporter expression in rat hepatic ischemia-reperfusion. Transplantation. 82: 258-66. PMID 16858290 DOI: 10.1097/01.Tp.0000226243.69023.54  0.536
2006 Cheng X, Maher J, Lu H, Klaassen CD. Endocrine regulation of gender-divergent mouse organic anion-transporting polypeptide (Oatp) expression. Molecular Pharmacology. 70: 1291-7. PMID 16807376 DOI: 10.1124/Mol.106.025122  0.746
2006 Maher JM, Slitt AL, Callaghan TN, Cheng X, Cheung C, Gonzalez FJ, Klaassen CD. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. Biochemical Pharmacology. 72: 512-22. PMID 16806085 DOI: 10.1016/J.Bcp.2006.03.016  0.754
2006 Maher JM, Cheng X, Tanaka Y, Scheffer GL, Klaassen CD. Hormonal regulation of renal multidrug resistance-associated proteins 3 and 4 (Mrp3 and Mrp4) in mice. Biochemical Pharmacology. 71: 1470-8. PMID 16529719 DOI: 10.1016/J.Bcp.2006.02.005  0.71
2006 Moffit JS, Aleksunes LM, Maher JM, Scheffer GL, Klaassen CD, Manautou JE. Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor alpha. The Journal of Pharmacology and Experimental Therapeutics. 317: 537-45. PMID 16467456 DOI: 10.1124/Jpet.105.093765  0.644
2006 Maher JM, Cherrington NJ, Slitt AL, Klaassen CD. Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6. Life Sciences. 78: 2219-25. PMID 16260000 DOI: 10.1016/J.Lfs.2005.09.016  0.673
2005 Cheng X, Maher J, Dieter MZ, Klaassen CD. Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 1276-82. PMID 15919853 DOI: 10.1124/Dmd.105.003988  0.756
2005 Cheng X, Maher J, Chen C, Klaassen CD. Tissue distribution and ontogeny of mouse organic anion transporting polypeptides (Oatps). Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 1062-73. PMID 15843488 DOI: 10.1124/Dmd.105.003640  0.706
2005 Maher JM, Cheng X, Slitt AL, Dieter MZ, Klaassen CD. Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 956-62. PMID 15833929 DOI: 10.1124/Dmd.105.003798  0.751
2005 Maher JM, Slitt AL, Cherrington NJ, Cheng X, Klaassen CD. Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 947-55. PMID 15802388 DOI: 10.1124/Dmd.105.003780  0.75
2005 Tanaka Y, Slitt AL, Leazer TM, Maher JM, Klaassen CD. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochemical and Biophysical Research Communications. 326: 181-7. PMID 15567169 DOI: 10.1016/J.Bbrc.2004.11.012  0.635
2004 Dieter MZ, Maher JM, Cheng X, Klaassen CD. Expression and regulation of the sterol half-transporter genes ABCG5 and ABCG8 in rats. Comparative Biochemistry and Physiology. Toxicology & Pharmacology : Cbp. 139: 209-18. PMID 15683829 DOI: 10.1016/J.Cca.2004.11.002  0.74
2003 Cherrington NJ, Slitt AL, Maher JM, Zhang XX, Zhang J, Huang W, Wan YJ, Moore DD, Klaassen CD. Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 1315-9. PMID 14570762 DOI: 10.1124/Dmd.31.11.1315  0.619
2003 Slitt AL, Cherrington NJ, Maher JM, Klaassen CD. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 1176-86. PMID 12920174 DOI: 10.1124/Dmd.31.9.1176  0.554
Show low-probability matches.